A Phase III Multinational Multicenter Investigator-Masked Randomized Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension

Clinical trial NCT04133311 · COMPLETED

Trial details

NCT number: NCT04133311
Sponsor: Santen SAS
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Open-Angle Glaucoma or Ocular Hypertension Ocular Surface Disease

Start date: 2019-04-10
Primary completion: 2022-02-03
Enrollment: 386

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.